These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 541369)

  • 21. Risk of acute non-specific upper respiratory tract infections in healthy men taking dapsone-pyrimethamine for prophylaxis against malaria.
    Lee PS; Lau EY
    Br Med J (Clin Res Ed); 1988 Mar; 296(6626):893-5. PubMed ID: 3129063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug prevention of malaria.
    Br Med J (Clin Res Ed); 1981 Mar; 282(6268):988-9. PubMed ID: 6781690
    [No Abstract]   [Full Text] [Related]  

  • 23. Chemoprophylaxis against malaria in Papua New Guinea: a trial of amodiaquine and a combination of dapsone and pyrimethamine.
    Vrbova H; Gibney S; Gibson FD; Jolley D; Heywood PF; Stace J; Trenholme KR; Alpers MP
    P N G Med J; 1992 Dec; 35(4):275-84. PubMed ID: 1341089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The suppression of Plasmodium falciparum and Plasmodium vivax parasitaemias by a dapsone-pyrimethamine combination.
    Segal HE; Pearlman EJ; Thiemanun W; Castaneda BF; Ames CW
    J Trop Med Hyg; 1973 Nov; 76(11):285-90. PubMed ID: 4586093
    [No Abstract]   [Full Text] [Related]  

  • 25. Malaria in travelers returning from Kenya: failure of self-treatment with pyrimethamine/sulfadoxine.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1989 May; 38(20):363-4. PubMed ID: 2497333
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of two strategies for control of malaria within a primary health care programme in the Gambia.
    Greenwood BM; Greenwood AM; Bradley AK; Snow RW; Byass P; Hayes RJ; N'Jie AB
    Lancet; 1988 May; 1(8595):1121-7. PubMed ID: 2896957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma concentrations of sulfadoxine-pyrimethamine and of mefloquine during regular long term malaria prophylaxis.
    Hellgren U; Angel VH; Bergqvist Y; Arvidsson A; Forero-Gomez JS; Rombo L
    Trans R Soc Trop Med Hyg; 1990; 84(1):46-9. PubMed ID: 2345926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of acetylator phenotype of the leprosy patient on the emergence of dapsone resistant leprosy.
    Raj PP; Aschhoff M; Lilly L; Balakrishnan S
    Indian J Lepr; 1988 Jul; 60(3):400-6. PubMed ID: 3058828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of diaminodiphenylsulphonepyrimethamine and sulfadoxine-pyrimethamine combinations in the treatment of falciparum malaria in Thailand.
    Segal HE; Chinvanthananond P; Laixuthai B; Pearlman EJ; Hall AP; Phintuyothin P; Na-Nakorn A; Castaneda BF
    Trans R Soc Trop Med Hyg; 1975; 69(1):139-42. PubMed ID: 1096374
    [No Abstract]   [Full Text] [Related]  

  • 30. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
    Gosling RD; Gesase S; Mosha JF; Carneiro I; Hashim R; Lemnge M; Mosha FW; Greenwood B; Chandramohan D
    Lancet; 2009 Oct; 374(9700):1521-32. PubMed ID: 19765815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malaria prophylaxis.
    Fox JS
    Med J Aust; 1981 Aug; 2(4):202-3. PubMed ID: 7029226
    [No Abstract]   [Full Text] [Related]  

  • 32. Hypersensitivity syndrome associated with dapsone/pyrimethamine (Maloprim) antimalaria chemoprophylaxis.
    Thong BY; Leong KP; Chng HH
    Ann Allergy Asthma Immunol; 2002 May; 88(5):527-9. PubMed ID: 12027077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular immune responses to Plasmodium falciparum antigens in children receiving long term anti-malarial chemoprophylaxis.
    Otoo LN; Riley EM; Menon A; Byass P; Greenwood BM
    Trans R Soc Trop Med Hyg; 1989; 83(6):778-82. PubMed ID: 2515634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malaria prophylaxis for travellers.
    Cook IF
    Med J Aust; 1985 Apr; 142(7):427. PubMed ID: 3884983
    [No Abstract]   [Full Text] [Related]  

  • 35. Measurement of physiological concentrations of dapsone and its monoacetyl metabolite: a miniaturised assay for liquid or filter paper-absorbed samples.
    Mberu EK; Muhia DK; Minyiri GO; Njonge EW; Watkins WM
    J Chromatogr B Biomed Appl; 1996 Mar; 677(2):385-7. PubMed ID: 8704946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maloprim malaria prophylaxis in children living in a holoendemic village in north-eastern Tanzania.
    Lemnge MM; Msangeni HA; Rønn AM; Salum FM; Jakobsen PH; Mhina JI; Akida JA; Bygbjerg IC
    Trans R Soc Trop Med Hyg; 1997; 91(1):68-73. PubMed ID: 9093633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study of the efficacy of chloroquine and a combination of dapsone and pyrimethamine in the prophylaxis of malaria in Peninsular Malaysia.
    Ponnampalam JT; Seow CL; Roy OS
    J Trop Med Hyg; 1976 Oct; 79(10):220-5. PubMed ID: 796479
    [No Abstract]   [Full Text] [Related]  

  • 38. Malaria chemoprophylaxis, infection of the placenta and birth weight in Gambian primigravidae.
    Menendez C; Todd J; Alonso PL; Lulat S; Francis N; Greenwood BM
    J Trop Med Hyg; 1994 Aug; 97(4):244-8. PubMed ID: 8064949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Agranulocytosis during malaria prophylaxis with Maloprim (pyrimethamine and dapsone).
    Booth F; Barker LC; Barton CJ; Naik RB
    Postgrad Med J; 1984 Aug; 60(706):566-7. PubMed ID: 6473241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The distribution of birth weights in Gambian women who received malaria chemoprophylaxis during their first pregnancy and in control women.
    Greenwood AM; Menendez C; Todd J; Greenwood BM
    Trans R Soc Trop Med Hyg; 1994; 88(3):311-2. PubMed ID: 7974672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.